All Curated Mutation Sites in HIV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HIV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Show All
  
IN
  
RT
  
LTR
  
CA
  
Gag
  
Nef
  
Env
  
gp120
  
gp160
  
gp41
  
gp140
  
MA
  
Pol
  
PR
  
Rev
  
Tat
  
Vpu
  
Vif
  
Vpr
  

Keyword: Vif
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 32665270 G48A
Vif
Vif
Acquired Immunodeficiency Syndrome
D
G
S
I
View
2 32665270 P16A
Vif
Vif
Acquired Immunodeficiency Syndrome
D
G
S
I
View
3 33437166 Q135P
Vif
Vif
Acquired Immunodeficiency Syndrome
D
G
L
View
4 26537685 E171A
Vif
Vif
HIV Infections
G
R
I
T
View
5 26537685 E76A
Vif
Vif
HIV Infections
G
R
I
T
View
6 26537685 R173A
Vif
Vif
HIV Infections
G
R
I
T
View
7 26537685 R17A
Vif
Vif
HIV Infections
G
R
I
T
View
8 28302150 5WQVM8>4A
Vif
Vif
HIV Infections
G
T
View
9 28302150 9IVW11>3A
Vif
Vif
HIV Infections
G
T
View
10 28302150 D37A-W38A
Vif
Vif
HIV Infections
G
T
View
11 28302150 E45A-S46A
Vif
Vif
HIV Infections
G
T
View
12 28302150 H27A-H28A
Vif
Vif
HIV Infections
G
T
View
13 28302150 H56A
Vif
Vif
HIV Infections
G
T
View
14 28302150 I51A-S52A
Vif
Vif
HIV Infections
G
T
View
15 28302150 I57A–P58A
Vif
Vif
HIV Infections
G
T
View
16 28302150 I9A-V10A
Vif
Vif
HIV Infections
G
T
View
17 28302150 M16A
Vif
Vif
HIV Infections
G
T
View
18 28302150 N19A
Vif
Vif
HIV Infections
G
T
View
19 28302150 P49A-K50A
Vif
Vif
HIV Infections
G
T
View
20 28302150 Q12A–V13A
Vif
Vif
HIV Infections
G
T
View
21 28302150 R17A
Vif
Vif
HIV Infections
G
T
View
22 28302150 R23A–L24A
Vif
Vif
HIV Infections
G
T
View
23 28302150 S53A–E54A
Vif
Vif
HIV Infections
G
T
View
24 28302150 T20A
Vif
Vif
HIV Infections
G
T
View
25 28302150 T47A-N48A
Vif
Vif
HIV Infections
G
T
View
26 28302150 V55A
Vif
Vif
HIV Infections
G
T
View
27 28302150 V7A-M8A
Vif
Vif
HIV Infections
G
T
View
28 28302150 W11A
Vif
Vif
HIV Infections
G
T
View
29 28302150 W5A
Vif
Vif
HIV Infections
G
T
View
30 28302150 W5A-Q6A
Vif
Vif
HIV Infections
G
T
View
31 31262272 G101D
Vif
Vif
HIV Infections
G
R
S
C
L
View
32 31262272 G101S
Vif
Vif
HIV Infections
G
R
S
C
L
View
33 31262272 K33R
Vif
Vif
HIV Infections
G
R
S
C
L
View
34 31262272 K63R
Vif
Vif
HIV Infections
G
R
S
C
L
View
35 31262272 N36K
Vif
Vif
HIV Infections
G
R
S
C
L
View
36 31262272 N36S
Vif
Vif
HIV Infections
G
R
S
C
L
View
37 31262272 R34K
Vif
Vif
HIV Infections
G
R
S
C
L
View
38 31262272 R92G
Vif
Vif
HIV Infections
G
R
S
C
L
View
39 31262272 V31I
Vif
Vif
HIV Infections
G
R
S
C
L
View
40 24418540 D14A
Vif
Vif
Cell line
G
View
41 24418540 E88A
Vif
Vif
Cell line
G
View
42 24418540 G84D
Vif
Vif
Cell line
G
View
43 24418540 R15A
Vif
Vif
Cell line
G
View
44 24418540 W21A
Vif
Vif
Cell line
G
View
45 24418540 W38A
Vif
Vif
Cell line
G
View
46 24418540 W89A
Vif
Vif
Cell line
G
View
47 24418540 Y40A
Vif
Vif
Cell line
G
View
48 24418540 Y69A
Vif
Vif
Cell line
G
View
49 24422669 H108A
Vif
Vif
Cell line
G
View
50 24422669 H27A
Vif
Vif
Cell line
G
View
51 24422669 H28A
Vif
Vif
Cell line
G
View
52 24422669 I31A
Vif
Vif
Cell line
G
View
53 24422669 L24A
Vif
Vif
Cell line
G
View
54 24422669 M29A
Vif
Vif
Cell line
G
View
55 24422669 R23A
Vif
Vif
Cell line
G
View
56 24422669 V25A
Vif
Vif
Cell line
G
View
57 24422669 Y30A
Vif
Vif
Cell line
G
View
58 31665623 G33K
Vif
Vif
HIV Infections
G
R
S
T
View
59 31665623 G33R
Vif
Vif
HIV Infections
G
R
S
T
View
60 31665623 G75T
Vif
Vif
HIV Infections
G
R
S
T
View
61 31665623 I31F
Vif
Vif
HIV Infections
G
R
S
View
62 31665623 I31V
Vif
Vif
HIV Infections
G
R
S
T
View
63 31665623 K22A
Vif
Vif
HIV Infections
G
R
S
View
64 31665623 K22T
Vif
Vif
HIV Infections
G
R
S
View
65 31665623 K26A
Vif
Vif
HIV Infections
G
R
S
View
66 31665623 K36A
Vif
Vif
HIV Infections
G
R
S
View
67 31665623 L72R
Vif
Vif
HIV Infections
G
R
S
T
View
68 31665623 N140Y
Vif
Vif
HIV Infections
G
R
S
T
View
69 31665623 N48T
Vif
Vif
HIV Infections
G
R
S
View
70 31665623 Q105R
Vif
Vif
HIV Infections
G
R
S
T
View
71 31665623 Q83H
Vif
Vif
HIV Infections
G
R
S
T
View
72 31665623 R15S
Vif
Vif
HIV Infections
G
R
S
View
73 31665623 R23A
Vif
Vif
HIV Infections
G
R
S
T
View
74 31665623 R33A
Vif
Vif
HIV Infections
G
R
S
View
75 31665623 R33G
Vif
Vif
HIV Infections
G
R
S
View
76 31665623 V31I
Vif
Vif
HIV Infections
G
R
S
T
View
77 30808702 V142I
Vif
Vif
Cell line
G
R
S
View
78 32446377 I31V
Vif
Vif
HIV Infections
G
View
79 32446377 K36R
Vif
Vif
HIV Infections
D
G
View
80 32446377 K50R
Vif
Vif
HIV Infections
G
View
81 32446377 N48H
Vif
Vif
HIV Infections
G
View
82 32446377 R33G
Vif
Vif
HIV Infections
G
View
83 32446377 R33K
Vif
Vif
HIV Infections
G
View
84 32446377 T47P
Vif
Vif
HIV Infections
G
View
85 31266880 G5177A
Vif
Vif
Cell line
D
G
R
View
86 31266880 S46N
Vif
Vif
Cell line
D
G
R
View
87 32960906 R132S
Vif
Vif
HIV Infections
D
G
R
L
View
88 16201018 E45G
Vif
Vif
HIV Infections
G
S
View
89 16201018 F115S
Vif
Vif
HIV Infections
G
S
View
90 16201018 G138R
Vif
Vif
HIV Infections
G
S
View
91 16201018 G143R
Vif
Vif
HIV Infections
G
S
View
92 16201018 G185R
Vif
Vif
HIV Infections
G
S
View
93 16201018 G75R
Vif
Vif
HIV Infections
G
S
View
94 16201018 K22E
Vif
Vif
HIV Infections
G
S
View
95 16201018 K63E
Vif
Vif
HIV Infections
G
S
View
96 16201018 L150P
Vif
Vif
HIV Infections
G
S
View
97 16201018 S32P
Vif
Vif
HIV Infections
G
S
View
98 16201018 Y40H
Vif
Vif
HIV Infections
G
S
View
Contents
Description

The table shows all curated mutation sites of HIV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.